This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What's in the Cards for National Steel's (SID) Q3 Earnings?
by Zacks Equity Research
National Steel's (SID) Q3 results will likely reflect solid demand for steel on strong recovery in the automotive and construction markets, while high raw material costs might have been a spoilsport.
Albemarle (ALB) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and prices in its lithium unit in Q3.
Westlake Chemical (WLK) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Westlake Chemical's (WLK) Q3 performance is likely to have benefited from higher demand for polyethylene and PVC resin.
Allegheny (ATI) Earnings and Revenues Beat Estimates in Q3
by Zacks Equity Research
Allegheny's (ATI) third-quarter results benefit from increased volumes in its HPMC unit and cost-reduction measures.
The Zacks Analyst Blog Highlights: Carter's, Ralph Lauren, Synaptics, Chemours and Cushman & Wakefield
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Carter's, Ralph Lauren, Synaptics, Chemours and Cushman & Wakefield
Chemours (CC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Chemours (CC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Newmont's (NEM) Earnings and Sales Lag Estimates in Q3
by Zacks Equity Research
Newmont's (NEM) Q3 earnings are impacted by lower realized prices and higher costs.
Agnico Eagle (AEM) Q3 Earnings Lag, Sales Beat Estimates
by Zacks Equity Research
Agnico Eagle (AEM) delivers record gold production in the third quarter including production at Hope Bay.
Cameco Corp (CCJ) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Cameco Corp's (CCJ) third-quarter 2021 results are likely to reflect resumption of production at Cigar Lake mine, higher average realized uranium prices and cost cutting efforts.
DuPont (DD) Gears Up for Q3 Earnings: What's in the Offing?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from higher demand and its cost and productivity actions amid headwinds from higher raw material costs in Q3.
FMC Corp (FMC) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Higher demand and new product launches are likely to have aided FMC Corp's (FMC) Q3 performance amid headwinds from higher raw materials and logistics costs.
5 Mid-Cap Growth Picks Ahead of Earnings for Long-Term Gain
by Nalak Das
We have narrowed down our search to five mid-cap growth stocks that will report earnings results within next week. These are: RL, SYNA, CC, CRI and CWK.
Mosaic (MOS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Mosaic's (MOS) Q3 results are likely to reflect the benefits of higher prices and demand for phosphate and potash.
Is The Chemours (CC) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Is (CC) Outperforming Other Basic Materials Stocks This Year?
LyondellBasell (LYB) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q3 performance is likely to have benefited from strong consumer-driven demand and continued recovery in the durable goods market.
AdvanSix (ASIX) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
AdvanSix (ASIX) is expected to have benefited from strong end-market demand, higher prices and growth of its differentiated products in Q3.
Nutrien (NTR) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Nutrien's (NTR) third-quarter results are likely to reflect the benefits of strong demand and higher prices for fertilizers.
Chemours (CC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Chemours (CC) closed at $28.95, marking a -1.63% move from the previous day.
Sherwin-Williams (SHW) Earnings & Sales Beat Estimates in Q3
by Zacks Equity Research
Sherwin-Williams' (SHW) Q3 results benefit from strong demand in its pro-architectural and industrial end markets amid headwinds from raw material supply chain challenges.
Eastman Chemical (EMN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Eastman Chemical's (EMN) Q3 performance is likely to have benefited from cost-management actions and new business revenues from innovation.
Newmont (NEM) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Newmon''s (NEM) results in the third quarter are likely to reflect the weakness in gold prices.
Chemours (CC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Chemours (CC) closed the most recent trading day at $29.43, moving +0.82% from the previous trading session.
Are Investors Undervaluing Chemours (CC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Methanex (MEOH) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Methanex's (MEOH) third-quarter performance is likely to reflect healthy methanol demand and improvement in pricing.
Can Linde (LIN) Keep the Earnings Surprise Streak Alive in Q3?
by Zacks Equity Research
Higher industrial gas sales are likely to have aided Linde???s (LIN) Q3 earnings.